Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 1/2012

01.01.2012 | 2011 SSAT Plenary Presentation

A Root-Cause Analysis of Mortality Following Major Pancreatectomy

verfasst von: Charles Mahlon Vollmer Jr., Norberto Sanchez, Stephen Gondek, John McAuliffe, Tara S. Kent, John D. Christein, Mark P. Callery, The Pancreatic Surgery Mortality Study Group

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Although mortality rates from pancreatectomy have decreased worldwide, death remains an infrequent but profound event at an individual practice level. Root-cause analysis is a retrospective method commonly employed to understand adverse events. We evaluate whether emerging mortality risk assessment tools sufficiently predict and account for actual clinical events that are often identified by root-cause analysis.

Methods

We assembled a Pancreatic Surgery Mortality Study Group comprised of 36 pancreatic surgeons from 15 institutions in 4 countries. Mortalities after pancreatectomy (30 and 90 days) were accrued from 2000 to 2010. For root-cause analysis, each surgeon “deconstructed” the clinical events preceding a death to determine cause. We next tested whether mortality risk assessment tools (ASA, POSSUM, Charlson, SOAR, and NSQIP) could predict those patients who would die (n = 218) and compared their prognostic accuracy against a cohort of resections in which no patient died (n = 1,177).

Results

Two hundred eighteen deaths (184 Whipple’s resection, 18 distal pancreatectomies, and 16 total pancreatectomies) were identified from 11,559 pancreatectomies performed by surgeons whose experience averaged 14.5 years. Overall 30- and 90-day mortalities were 0.96% and 1.89%, respectively. Individual surgeon rates ranged from 0% to 4.7%. Only 5 patients died intraoperatively, while the other 213 succumbed at a median of 29 days. Mean patient age was 70 years old (38% were >75 years old). Malignancy was the indication in 90% of cases, mostly pancreatic cancer (57%). Median operative time was 365 min and estimated blood loss was 700 cc (range, 100–16,000 cc). Vascular repair or multivisceral resections were required for 19.7% and 15.1%, respectively. Seventy-seven percent had a variety of major complications before death. Eighty-seven percent required intensive care unit care, 55% were transfused, and 35% were reoperated upon. Fifty percent died during the index admission, while another 11% died after a readmission. Almost half (n = 107) expired between 31 and 90 days. Only 11% had autopsies. Operation-related complications contributed to 40% of deaths, with pancreatic fistula being the most evident (14%). Technical errors (21%) and poor patient selection (15%) were cited by surgeons. Of deaths, 5.5% had associated cancer progression—all occurring between 31 and 90 days. Even after root-cause scrutiny, the ultimate cause of death could not be determined for a quarter of the patients—most often between 31 and 90 days. While assorted risk models predicted mortality with variable discrimination from nonmortalities, they consistently underestimated the actual mortality events we report.

Conclusion

Root-cause analysis suggests that risk prediction should include, if not emphasize, operative factors related to pancreatectomy. While risk models can distinguish between mortalities and nonmortalities in a collective fashion, they vastly miscalculate the actual chance of death on an individual basis. This study reveals the contributions of both comorbidities and aggressive surgical decisions to mortality.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hunt VC, Budd JW. Transduodenal resection of the ampulla of Vater for carcinoma of the distal end of the common duct with restoration of continuity of the common and pancreatic ducts with the duodenum. SG&O 1935; 61:651–661. Hunt VC, Budd JW. Transduodenal resection of the ampulla of Vater for carcinoma of the distal end of the common duct with restoration of continuity of the common and pancreatic ducts with the duodenum. SG&O 1935; 61:651–661.
2.
Zurück zum Zitat Howard JM. Pancreatico-duodenectomy: forty-one consecutive Whipple resections without an operative mortality. Ann Surg. 1968 Oct;168(4):629–40.PubMedCrossRef Howard JM. Pancreatico-duodenectomy: forty-one consecutive Whipple resections without an operative mortality. Ann Surg. 1968 Oct;168(4):629–40.PubMedCrossRef
3.
Zurück zum Zitat Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J.One hundred and forty-five consecutive pancreaticoduodenectomies without mortality.Ann Surg. 1993 May;217(5):430–5.PubMedCrossRef Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J.One hundred and forty-five consecutive pancreaticoduodenectomies without mortality.Ann Surg. 1993 May;217(5):430–5.PubMedCrossRef
4.
Zurück zum Zitat Crile G Jr. The advantages of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic cancer. SG&O 1970; 130:1049–1053. Crile G Jr. The advantages of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic cancer. SG&O 1970; 130:1049–1053.
5.
Zurück zum Zitat Crist DW, Sitzman JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987; 206:358–365.PubMedCrossRef Crist DW, Sitzman JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987; 206:358–365.PubMedCrossRef
6.
Zurück zum Zitat Trede M, Schwall G, Saeger H. Survival after pancreaticoduodenectomy. Ann Surg 1990; 211:447–458.PubMedCrossRef Trede M, Schwall G, Saeger H. Survival after pancreaticoduodenectomy. Ann Surg 1990; 211:447–458.PubMedCrossRef
7.
Zurück zum Zitat Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival following pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161:120–125.PubMedCrossRef Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival following pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161:120–125.PubMedCrossRef
8.
Zurück zum Zitat McPhee JT, Hill JS, Whalen GF, Zayaruzny M, Litwin DE, Sullivan ME, Anderson FA, Tseng JF. Perioperative mortality for pancreatectomy: a national perspective. Ann Surg. 2007 Aug;246(2):246–53.PubMedCrossRef McPhee JT, Hill JS, Whalen GF, Zayaruzny M, Litwin DE, Sullivan ME, Anderson FA, Tseng JF. Perioperative mortality for pancreatectomy: a national perspective. Ann Surg. 2007 Aug;246(2):246–53.PubMedCrossRef
9.
Zurück zum Zitat Eppsteiner RW, Csikesz NG, McPhee JT, Tseng JF, Shah SA. Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg. 2009 Apr;249(4):635–40.PubMedCrossRef Eppsteiner RW, Csikesz NG, McPhee JT, Tseng JF, Shah SA. Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg. 2009 Apr;249(4):635–40.PubMedCrossRef
10.
Zurück zum Zitat Hill JS, McPhee JT, Whalen GF, Sullivan ME, Warshaw AL, Tseng JF. In-hospital mortality after pancreatic resection for chronic pancreatitis: population-based estimates from the nationwide inpatient sample. J Am Coll Surg. 2009 Oct;209(4):468–76. Epub 2009 Aug 20.PubMedCrossRef Hill JS, McPhee JT, Whalen GF, Sullivan ME, Warshaw AL, Tseng JF. In-hospital mortality after pancreatic resection for chronic pancreatitis: population-based estimates from the nationwide inpatient sample. J Am Coll Surg. 2009 Oct;209(4):468–76. Epub 2009 Aug 20.PubMedCrossRef
11.
Zurück zum Zitat Murphy MM, Knaus WJ 2nd, Ng SC, Hill JS, McPhee JT, Shah SA, Tseng JF. Total pancreatectomy: a national study. HPB (Oxford). 2009 Sep;11(6):476–82.CrossRef Murphy MM, Knaus WJ 2nd, Ng SC, Hill JS, McPhee JT, Shah SA, Tseng JF. Total pancreatectomy: a national study. HPB (Oxford). 2009 Sep;11(6):476–82.CrossRef
12.
Zurück zum Zitat Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000 Nov–Dec;4(6):567–79.PubMedCrossRef Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000 Nov–Dec;4(6):567–79.PubMedCrossRef
13.
Zurück zum Zitat Fernández-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg. 1995 Mar;130(3):295–9; discussion 299–300.PubMedCrossRef Fernández-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg. 1995 Mar;130(3):295–9; discussion 299–300.PubMedCrossRef
14.
Zurück zum Zitat Vollmer, C.M., Jr., Pratt, W., Vanounou, T., et al., Quality assessment in high-acuity surgery: volume and mortality are not enough. Arch Surg, 2007. 142(4): p. 371–80.PubMedCrossRef Vollmer, C.M., Jr., Pratt, W., Vanounou, T., et al., Quality assessment in high-acuity surgery: volume and mortality are not enough. Arch Surg, 2007. 142(4): p. 371–80.PubMedCrossRef
15.
Zurück zum Zitat Birkmeyer JD, SiewersAE, Finlayson EVA, et al. Hospital volume and surgical mortiality in the United States. N Engl J Med 2002; 346:1128–1137.PubMedCrossRef Birkmeyer JD, SiewersAE, Finlayson EVA, et al. Hospital volume and surgical mortiality in the United States. N Engl J Med 2002; 346:1128–1137.PubMedCrossRef
16.
Zurück zum Zitat Carroll JE, Smith JK, Simons JP, Murphy MM, Ng SC, Shah SA, Zhou Z, Tseng JF. Redefining mortality after pancreatic cancer resection. J Gastrointest Surg. 2010 Nov;14(11):1701–8. Epub 2010 Sep 16.PubMedCrossRef Carroll JE, Smith JK, Simons JP, Murphy MM, Ng SC, Shah SA, Zhou Z, Tseng JF. Redefining mortality after pancreatic cancer resection. J Gastrointest Surg. 2010 Nov;14(11):1701–8. Epub 2010 Sep 16.PubMedCrossRef
17.
Zurück zum Zitat Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007 May;204(5):854–62.PubMedCrossRef Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007 May;204(5):854–62.PubMedCrossRef
18.
Zurück zum Zitat Peleg O, Givot N, Halamish-Shani T, Taicher S. Wrong tooth extraction: root cause analysis. Quintessence Int 2010;41(10):869–72.PubMed Peleg O, Givot N, Halamish-Shani T, Taicher S. Wrong tooth extraction: root cause analysis. Quintessence Int 2010;41(10):869–72.PubMed
19.
Zurück zum Zitat Perkins JD, Levy AE, Duncan JB, Carithers RL. Using root cause analysis to improve survival in a liver transplant program. J Surg Res 2005;129(1):6–16.PubMedCrossRef Perkins JD, Levy AE, Duncan JB, Carithers RL. Using root cause analysis to improve survival in a liver transplant program. J Surg Res 2005;129(1):6–16.PubMedCrossRef
20.
Zurück zum Zitat Ahmed AR, Miskovic D, Vijayaseelan T, O’Malley W, Hanna GB. Root cause analysis of internal hernia and Roux limb compression after laparoscopic Roux-en-Y gastric bypass using observational clinical human reliability assessment. Surg Obes Relat Dis 2011 Jan 14. doi:10.1016/j.soard.2010.12.009. Ahmed AR, Miskovic D, Vijayaseelan T, O’Malley W, Hanna GB. Root cause analysis of internal hernia and Roux limb compression after laparoscopic Roux-en-Y gastric bypass using observational clinical human reliability assessment. Surg Obes Relat Dis 2011 Jan 14. doi:10.​1016/​j.​soard.​2010.​12.​009.
21.
Zurück zum Zitat Copeland GP, Jones D, and Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991; 78:356–360.CrossRef Copeland GP, Jones D, and Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991; 78:356–360.CrossRef
22.
Zurück zum Zitat Pratt, W., Joseph, S., Callery, M.P., et al., POSSUM accurately predicts morbidity for pancreatic resection. Surgery, 2008. 143(1): p. 8–19.PubMedCrossRef Pratt, W., Joseph, S., Callery, M.P., et al., POSSUM accurately predicts morbidity for pancreatic resection. Surgery, 2008. 143(1): p. 8–19.PubMedCrossRef
23.
Zurück zum Zitat Hill JS, Zhou Z, Simons JP, Ng SC, McDade TP, Whalen GF, Tseng JF. A simple risk score to predict in-hospital mortality after pancreatic resection for cancer. Ann Surg Oncol. 2010 Jul;17(7):1802–7.PubMedCrossRef Hill JS, Zhou Z, Simons JP, Ng SC, McDade TP, Whalen GF, Tseng JF. A simple risk score to predict in-hospital mortality after pancreatic resection for cancer. Ann Surg Oncol. 2010 Jul;17(7):1802–7.PubMedCrossRef
24.
Zurück zum Zitat Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, Winslow ER, Cho CS, Weber SM. Preoperative Factors Predict Perioperative Morbidity and Mortality After Pancreaticoduodenectomy. Ann Surg Oncol. 2011 Aug;18(8):2126–35. Feb 20. doi:10.1245/s10434-011-1594-6. Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, Winslow ER, Cho CS, Weber SM. Preoperative Factors Predict Perioperative Morbidity and Mortality After Pancreaticoduodenectomy. Ann Surg Oncol. 2011 Aug;18(8):2126–35. Feb 20. doi:10.​1245/​s10434-011-1594-6.
25.
Zurück zum Zitat Kelly KJ, Greenblatt DY, Wan Y, Rettammel RJ, Winslow E, Cho CS, Weber SM. Risk stratification for distal pancreatectomy utilizing ACS-NSQIP: preoperative factors predict morbidity and mortality. J Gastrointest Surg. 2011 Feb;15(2):250–9.PubMedCrossRef Kelly KJ, Greenblatt DY, Wan Y, Rettammel RJ, Winslow E, Cho CS, Weber SM. Risk stratification for distal pancreatectomy utilizing ACS-NSQIP: preoperative factors predict morbidity and mortality. J Gastrointest Surg. 2011 Feb;15(2):250–9.PubMedCrossRef
26.
Zurück zum Zitat Dindo D, Demartines N, and Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205–213.PubMedCrossRef Dindo D, Demartines N, and Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205–213.PubMedCrossRef
27.
Zurück zum Zitat Pratt W, Maithel SK, Vanounou T, Huang Z, Callery MP, Vollmer CM. Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) Classification Scheme. Annals of Surgery 2007 Mar.; 245(3):443–451.PubMedCrossRef Pratt W, Maithel SK, Vanounou T, Huang Z, Callery MP, Vollmer CM. Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) Classification Scheme. Annals of Surgery 2007 Mar.; 245(3):443–451.PubMedCrossRef
28.
Zurück zum Zitat Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, and Kim WR. A Model to Predict Survival in Patients With End-Stage Liver Disease Hepatology 2001; 33:464–470.PubMedCrossRef Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, and Kim WR. A Model to Predict Survival in Patients With End-Stage Liver Disease Hepatology 2001; 33:464–470.PubMedCrossRef
29.
Zurück zum Zitat New Classification of Physical Status. Anestesiology 1963;24:111 New Classification of Physical Status. Anestesiology 1963;24:111
30.
Zurück zum Zitat Pratt WB, Callery MP, and Vollmer CM. Risk prediction for Development of Pancreatic fistula Using the ISGPF Classification Scheme. World J Surg 2008; 32:419–428.PubMedCrossRef Pratt WB, Callery MP, and Vollmer CM. Risk prediction for Development of Pancreatic fistula Using the ISGPF Classification Scheme. World J Surg 2008; 32:419–428.PubMedCrossRef
31.
Zurück zum Zitat Pratt, W., Callery, M.P., and Vollmer, C.M., Jr., Optimal surgical performance attenuates physiologic risk in high-acuity operations. J Am Coll Surg, 2008. 207(5): p. 717–30.PubMedCrossRef Pratt, W., Callery, M.P., and Vollmer, C.M., Jr., Optimal surgical performance attenuates physiologic risk in high-acuity operations. J Am Coll Surg, 2008. 207(5): p. 717–30.PubMedCrossRef
Metadaten
Titel
A Root-Cause Analysis of Mortality Following Major Pancreatectomy
verfasst von
Charles Mahlon Vollmer Jr.
Norberto Sanchez
Stephen Gondek
John McAuliffe
Tara S. Kent
John D. Christein
Mark P. Callery
The Pancreatic Surgery Mortality Study Group
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 1/2012
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1753-x

Weitere Artikel der Ausgabe 1/2012

Journal of Gastrointestinal Surgery 1/2012 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.